News

Upcoming Investment Conferences Spotlight Foghorn Therapeutics

Upcoming Investment Conferences Spotlight Foghorn Therapeutics

Foghorn Therapeutics to Spotlight Innovations at Investor Conferences

Foghorn Therapeutics Inc. (NASDAQ: FHTX), a leading biotech company, is renowned for its groundbreaking work in the field of gene therapies aimed at addressing serious diseases through the innovative correction of abnormal gene expression. Situated in CAMBRIDGE, this clinical-stage company is set to participate in two vital investor conferences that will showcase its commitment to transforming healthcare.

Conferences Involved

Foghorn’s management team will be attending the B. Riley Securities Precision Oncology and Radiopharma Conference, as well as the TD Cowen 45th Annual Health Care Conference. These platforms offer a unique opportunity for Adrian Gottschalk, the President and Chief Executive Officer, to highlight Foghorn's advancements in oncology and beyond.

B. Riley Securities Precision Oncology and Radiopharma Conference

At the B. Riley Securities Conference, scheduled for February 28, 2025, at 9 a.m. EST in New York City, Foghorn will feature in a Synthetic Lethality Panel. This panel is significant as it focuses on innovative cancer therapies that exploit specific vulnerabilities within cancer cells, offering new hope for treatment methodologies.

TD Cowen 45th Annual Health Care Conference

Following the B. Riley event, Foghorn will present at the TD Cowen Health Care Conference on March 3, 2025, at 2:30 p.m. EST in Boston. This presentation will further delve into the company’s research and product pipeline, showcasing its potential impact on healthcare.

Virtual One-On-One Meetings and Other Opportunities

On March 3, Foghorn Therapeutics will also engage in virtual one-on-one meetings for interested investors. These meetings provide an excellent chance for stakeholders to gain insights into the company's strategic goals and future direction.

Accessing Presentation Webcast

For those unable to attend, a webcast of these presentations will be accessible through the Investor section of Foghorn Therapeutics' website. This interactive platform ensures that even remote investors can stay informed about Foghorn's latest developments and innovations.

About Foghorn Therapeutics

Foghorn Therapeutics is dedicated to discovering and developing a unique class of medicines that caters to genetically defined dependencies within the chromatin regulatory system. Utilizing their advanced Gene Traffic Control platform, the company methodically studies, identifies, and validates promising drug targets within this complex area of genetics. With a focus on oncology, Foghorn Therapeutics is building a robust pipeline of product candidates, aiming to provide transformative therapies to those in need.

Foghorn’s Mission and Research Focus

Foghorn’s mission is to revolutionize treatment approaches for serious diseases through advanced gene therapies. As the understanding of genetic factors in diseases continues to grow, Foghorn is at the forefront of research that integrates these insights into practical, transformative treatments. The company continues to emphasize its commitment to innovation and patient-centered care.

Stay Connected with Foghorn Therapeutics

To learn more about Foghorn Therapeutics and their pioneering work, interested individuals can explore the company’s website at www.foghorntx.com. For the latest updates, follow Foghorn on social media platforms like X (formerly Twitter) and LinkedIn, as they share insights on their research progress and innovations.

Contact Information

If you have any inquiries, please reach out to Karin Hellsvik at Foghorn Therapeutics Inc. via email at khellsvik@foghorntx.com.

Frequently Asked Questions

What is the focus of Foghorn Therapeutics?

Foghorn Therapeutics focuses on developing gene therapies that correct abnormal gene expression to treat serious diseases, primarily in oncology.

Which upcoming conferences will Foghorn participate in?

Foghorn will participate in the B. Riley Securities Precision Oncology and Radiopharma Conference and the TD Cowen 45th Annual Health Care Conference.

Who will present at the conferences?

Adrian Gottschalk, the President and CEO of Foghorn, will be the key presenter at both conferences.

Can I access the presentations online?

Yes, the presentations will be available via webcast on Foghorn Therapeutics' Investor section of their website for those who cannot attend in person.

How can I contact Foghorn Therapeutics for more information?

You can contact Karin Hellsvik at Foghorn Therapeutics via email at khellsvik@foghorntx.com.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Hybrid Bonding Market Shooting to $2.45 Billion by 2033

Updated Category News Views 126

Hybrid Bonding: The Future of Semiconductor Interconnects? Mark these words: Hybrid bonding isn't just another tech trend—it’s morphing into a billion-dollar juggernaut, my friend. With the latest numbers from MarketsandMarkets™, we see a potential leap from USD 0.38 billion in 2026 to a staggering USD 2.45 billion by 2033. We'll be seeing an eye-popping CAGR of...

Continue Reading
vVARDIS Readies for Big Day on NYSE—IPO Set to Shine

Updated Category News Views 166

vVARDIS Stepping into the Spotlight of the NYSE Alright, folks, here's one that could make some waves. vVARDIS is gearing up for its NYSE debut, trading under the ticker VVVV. They're no small fry talking about 9.72 million shares priced at 18 bucks a pop. This isn't just any run-of-the-mill company; they claim to have the first peptide-containing formulation for early...

Continue Reading
CSTS Backs Hong Kong's Nobel Sustainability Trust Put

Updated Category News Views 150

A New Chapter for CSTS and Sustainability Leadership Who would've thunk it? CSTS Enterprises, primarily known for its integrated media and sports ventures, is stepping into the sustainability arena as the Official Hospitality Partner for the Nobel Sustainability Trust Hong Kong Summit 2026. They're not just dipping a toe—they're diving headfirst into the pool, bringing...

Continue Reading
Why Surge Protection Is Now a Vital Home Upgrade

Updated Category News Views 83

Understanding the Hidden Risks of Power Surges You ever had a computer or TV go kaput out of the blue? Chances are, power surges are the stealthy culprit. Zachary Bobersky, an expert electrician from Ungerman Electric, dishes out the hard truths about how these electrical hiccups, often triggered by everyday use—like your refrigerator or AC flicking on—can quietly...

Continue Reading
CVRx Faces Legal Storm: Investors Grapple with Fallout

Updated Category News Views 124

CVRx in the Crosshairs: Legal and Operational Woes There's a storm brewing over at CVRx, Inc. (NASDAQ: CVRX), and it's pulling investors down a hell of a financial rabbit hole. You might think you're in the clear with a company like CVRx that boasts approved devices, but think again. Recent revelations have shown that even those with FDA stamps aren't immune to the...

Continue Reading
DraftKings Shares Tumble, Investors Grapple with Losses

Updated Category News Views 60

DraftKings' Bold Moves Hit Investor Pockets Hard It ain't every day you see a company gamble nearly $700 million and come out with egg on its face. Yet, that's what DraftKings (NASDAQ: DKNG) seems to have done, and now it's shareholders who might be left holding the bag. On November 6, 2026, when DraftKings admitted it was doubling down on its Predictions business...

Continue Reading
Fly-E Faces Revenue Drop Amid Retail Restructuring

Updated Category News Views 131

Downturn Despite Strategic Restructuring Today, we're diving into Fly-E Group, Inc. (NASDAQ:FLYE) and the latest shakeup in their financials—spoiler alert, it's riding a downward slope. Quarter two of fiscal 2027 didn't exactly shine a light on profitability. Net revenues slid, dropping to $2.6 million this quarter, down from $3.9 million the previous year. Tack that up...

Continue Reading
Revolutionary Sports Ball Backpack: A Game Changer?

Updated Category News Views 37

Backpacks Reinvented by a Clever Mom Ever been caught in the whirlwind of juggling kids, sports gear, and school supplies? Well, one stay-at-home mom from Poway, California found herself in just such a predicament. She turned this everyday chaos into a creative solution by designing a unique Sports Ball Backpack. The idea came to her while managing a toddler, a newborn,...

Continue Reading
Mitsubishi CEO Chikumoto Wins 2026 Palladium Medal

Updated Category News Views 147

Here's something to tip your hat to: Manabu Chikumoto, the head honcho of Mitsubishi Chemical Group, snagged the 2026 International Palladium Medal. You don't get this one by just sitting pretty behind a desk. The folks at the Société de Chimie Industrielle—the ones responsible for this prestigious accolade—know a thing or two about setting high bars in the chemical...

Continue Reading
Thanksgiving in Outer Banks: Unique Traditions Await

Updated Category News Views 65

Thanksgiving Plans Off the Beaten Path Thanksgiving in the Outer Banks isn't just another holiday; it's a whole different ball game. Imagine trading in the usual family couch-potato marathon for a beachside gathering, where the sand replaces the snow, and coastal seafood joins the turkey on your dinner table. If you've been teetering on the edge of making plans, this...

Continue Reading

Top 5 Most Recently Viewed Articles

Nuix Secures Landmark Deal with German Tax Authority

Updated Category News Views 206

Nuix Partners with German Tax Authority to Enhance Investigative Processes Nuix, known for its innovative forensic analysis software, has secured a significant multiyear contract to provide its capabilities to the tax authority in Germany. This partnership with the agency in Rhineland-Palatinate marks a notable step forward in strengthening their regulatory and...

Continue Reading
reAlpha Tech Corp. Secures $2 Million in Recent Stock Offering

Updated Category News Views 237

reAlpha Tech Corp. Secures $2 Million in Recent Stock Offering reAlpha Tech Corp. (NASDAQ: AIRE), an innovative player in the AI-driven real estate technology sector, has successfully closed a public offering. This financing event, which amounted to approximately $2 million, involved the issuance of 13,333,334 shares of common stock along with accompanying warrants....

Continue Reading
OneStream Inc. Announces Participation in Major Investor Events

Updated Category News Views 133

OneStream's Upcoming Investor Conference Participation OneStream, Inc. (Nasdaq: OS), a frontrunner in enterprise finance management solutions, is set to participate in several key investor conferences. Their innovative platform revolutionizes the office of the CFO by integrating core financial and operational functions, which include financial closing, consolidation, and...

Continue Reading
SpaceX's Major Investment in xAI: A Sign of Growing AI Innovation

Updated Category News Views 335

SpaceX Makes Headlines with $2 Billion xAI Investment SpaceX has pledged a significant $2 billion investment into xAI, the artificial intelligence venture founded by Elon Musk. This funding represents a substantial portion of xAI's recent equity round, which totals $5 billion. With this undertaking, SpaceX demonstrates its unwavering support for Musk's ambitious vision of...

Continue Reading
Transforming Fishing: Innovations and Opportunities at the Fair

Updated Category News Views 319

Transforming Fishing: Innovations and Opportunities at the Fair Fishing has undergone a significant transformation in recent years, evolving from a leisurely pastime into a dynamic and technology-driven industry. The emergence of niche hobbies into mainstream activities has encouraged manufacturers to broaden their horizons. They are now appealing to a wider consumer...

Continue Reading